Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation

Clinical trial NCT06499857 · RECRUITING

Trial details

NCT number: NCT06499857
Sponsor: University of Chicago
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Overweight or Obesity Atrial Fibrillation

Start date: 2025-04-14
Primary completion: 2027-12-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.